TECH
BIO-TECHNE CorpCompany with tickers: TECH
CIK
842023
CUSIP
09073M104
Shares Outstanding
156,568,751
13F Activity (30d)
330 filings
299 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $311,415,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Revenue (ASC 606) | $311,415,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Cost of Revenue | — | ||||
| Gross Profit | $208,288,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Operating Expenses | $132,793,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Research & Development | — | ||||
| Operating Income | $75,495,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Net Income | $51,047,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| EPS (Basic) | $0.33 | USD/shares | 2026-03-31 | 10-Q | 2026-05-06 |
| EPS (Diluted) | $0.32 | USD/shares | 2026-03-31 | 10-Q | 2026-05-06 |